From transformation to the substance responsible
In 1928, Griffith reported transformation of pneumococcal types: live rough bacteria exposed to killed encapsulated bacteria could acquire corresponding traits. This raised a new question: what in dead bacteria could produce a stable change in living ones? Later work moved transformation into laboratory culture and showed that extracts without intact living donor cells could act, making chemical identification experimentally feasible.
Oswald Avery at New York's Rockefeller Institute for Medical Research had long studied pneumococci and their capsules. Colin MacLeod helped improve culture and transformation systems during the 1930s, addressing unstable activity assays. Maclyn McCarty joined in 1941 and participated in purification, chemical testing and enzyme studies. Their collaboration rested on years of methodological development, not a single experiment pouring several enzymes into test tubes.
Following biological activity through separation
The team prepared material from type III pneumococci and progressively removed proteins, capsular polysaccharides and other constituents. Samples retained at each step were tested for the ability to make suitable rough recipients produce type III capsules. Transformation served as the marker guiding separation. Purification was therefore not merely a quest for clean appearance but a repeated comparison of whether activity survived removal of particular components.
This approach also distinguished the inducing material from the capsule ultimately produced. Preparations still induced the appropriate polysaccharide after donor capsular polysaccharide had been removed, ruling out a simple explanation of attaching a pre-existing capsule to live bacteria. Transformed cells retained the new trait through further reproduction, making temporary stimulation or nutritional supplementation inadequate explanations of the whole phenomenon. The question therefore concerned transmissible cellular traits.
Chemical and physical tests point to nucleic acid
The 1944 paper reported that the active fraction possessed multiple properties of deoxyribonucleic acid, or DNA. Elemental composition, colour reactions, ultraviolet absorption and physical behaviour supported one another. Using the methods available, the researchers found no protein, free lipid or capsular polysaccharide sufficient to explain the activity. Highly purified preparations still induced type changes under appropriate culture conditions, tightening the connection between DNA and transformation.
The authors did not claim that their instruments excluded every conceivable trace impurity. They cautiously described the active fraction as consisting principally, perhaps entirely, of DNA. This qualification was part of the argument: elemental ratios close to theoretical values or apparent uniformity could not alone guarantee absolute purity. Experiments based on different principles were therefore needed to test whether activity disappeared when the same substance was destroyed.
References: [1]
Enzyme treatments require targeted controls
Treatments with trypsin, chymotrypsin and similar enzymes did not abolish transforming activity, and ribonuclease produced no detectable reduction. This weakened explanations assigning the effect to certain proteins or RNA. Conversely, enzyme preparations that depolymerized known DNA samples also destroyed transformation activity. Researchers compared other enzyme activities in those preparations to avoid arbitrarily assigning the effect to any one component of a mixture.
The 1944 evidence included crude enzyme preparations and should not be reproduced as the tidy array of pure-enzyme bottles familiar from later textbooks. In 1946, McCarty and Avery further reported that purified deoxyribonuclease irreversibly eliminated the transforming substance's biological activity. This strengthened the earlier conclusion. Distinguishing the years reveals how evidence accumulated from associated effects toward more specific verification.
The strength and limits of the 1944 conclusion
Their Journal of Experimental Medicine study connected a definite, heritable change in bacterial type with a particular chemical substance. It challenged the view that proteins principally carried hereditary specificity and made nucleic acids more than ordinary cellular constituents accompanying proteins. The crucial advance was simultaneously identifying the material's origin, the exclusion tests it had undergone and the stable change produced in recipient cells.
This did not mean that every organism's hereditary mechanism had been explained in 1944. The paper supplied neither DNA's double helix, rules of base coding nor a replication mechanism. Other traits and species required independent research. Later experiments strengthened DNA's status as hereditary material, but hindsight should not be written as immediate universal agreement. Avery's team brought heredity to a chemical level at which substances could be isolated, destroyed and repeatedly tested.